Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

India Intravenous Anesthetic Market– Insights

India is one of the highest populated countries in the world. The increasing geriatric population, changing lifestyle, and rising number of chronic diseases are expected to drive demand for intravenous anesthetics. For instance, according to the OECD (Organization for Economic Co-operation and Development), in India, around 10,000 heart bypass, 8,500 knee replacement, and 5,500 spinal fusion surgeries were performed in 2011. The surgical treatment cost advantage compared to other countries is a major factor that increases the number of surgeries conducted in India, which is expected to drive growth of the market over the forecast period. 

In addition, increasing government expenditure on healthcare sector is another factor that is expected to drive growth of the global intravenous anesthetic market. For instance, during 2016-2017, India Government spent around 1.02% of the total GDP (gross domestic product) and it increased to around 1.28% in the period 2017-2018. The increasing government spending on public health is to support each individual to gain needful treatment. It also helps to reduce treatment cost burden and provide treatment access to patient with chronic disease problems.

The India intravenous anesthetic market is estimated to be valued at US$ 65.0 million in 2019 and is expected to exhibit a CAGR of 2.6% over the forecast period (2020-2027).

India Intravenous Anesthetic Market Share (%) Analysis, By Type, 2019

India Intravenous Anesthetic  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Furthermore, increasing government support for public healthcare is a key driving factor that is expected to drive growth of the India intravenous anesthetic market. For instance, in 2018, the Government of India launched nationwide health care reform ‘Ayushman Bharat’. This scheme of Indian government had taken significant step towards universal health coverage. Under this scheme, poor and vulnerable families receives financial coverage for hospital expenses for secondary and tertiary care.

India Intravenous Anesthetic Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

India Intravenous Anesthetic  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

India Intravenous Anesthetic Market- Competitive Landscape

Major players operating in the India intravenous anesthetic market include AstraZeneca Plc, Fresenius Kabi, AbbVie Inc., Baxter International Inc., B. Braun Melsungen AG, Maruishi Pharmaceutical Co., Ltd, Piramal Healthcare, Hikma Pharmaceuticals, and Mylan N.V.

The group of fast-acting compounds that are used to induce complete sedation are known as intravenous anesthetics. Propofol, etomidate, ketamine, and barbiturates are the most commonly used intravenous anesthetics. Ketamine is used in the emergency medicine cases, owing to its strong dissociative, sympathomimetic, and analgesic effects. Propofol is the standard drug for induction of anesthesia and etomidate is most commonly used in the cases of hemodynamic instability. While, barbiturate helps to reduce intracranial pressure and it is useful for patients with high head trauma or intracranial pressure.

In addition, anaesthesiologists prefer to use injectable anaesthetics, as they work faster compared to other anaesthetics. IV (Intravenous) anesthetics are typically small and highly lipophilic molecules and being lipophilic, helps to facilitate their rapid preferential distribution into brain and spinal cord, as both the organ are highly vascularized and lipophilic.

Market Dynamics

India intravenous anaesthetic market growth is attributed to the increasing number of different surgical procedures that depend on IV anaesthesia. For instance, according to Obesity Surgery Society of India data, the weight loss surgeries performed in India are continuously increasing. In 2014, around 8 bariatric surgeries were performed in India and it reached around 20,242 in 2018. Moreover, in India the number of bariatric surgeons increased from 8 to 250 during 2004 to 2018.

The healthcare spending in India is continuously increasing over the time. For instance, according to the India Brand Equity Foundation (IBEF) data, India’s healthcare industry is expected to reach around US$ 372 Bn by 2022. The increasing investments in healthcare facilities is expected to boost demand for intravenous anaesthetics. For instance, in 2019, according to the National Investment Promotion and Facilitation Agency of India revealed some data of upcoming hospital projects in the country, in which, around US$ 243.74 million are setting up for the 500 number of bed multispecialty hospital in Dharamshala, India. Similarly, in Mumbai, around US$ 96.52 Mn was expected to invest for super-speciality hospital.

Key features of the study:

  • This report provides in-depth analysis of the market, India intravenous anesthetic market  size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period 2019-2027, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the India  intravenous anesthetic market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study include Fresenius Kabi, AbbVie Inc., Baxter International Inc., B. Braun Melsungen AG, Maruishi Pharmaceutical Co., Ltd, Piramal Healthcare, Hikma Pharmaceuticals, and Mylan N.V.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, market expansions, and marketing tactics
  • The India intravenous anesthetic market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers of reprocessed medical devices, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • India Intravenous Anesthetic Market, By Type:
    • Barbiturates
    • Ketamine
    • Benzodiazepines
    • Propofol
    • Others
  • India Intravenous Anesthetic Market, By End User:
    • Hospitals
    • Clinics
    • Others
  • Company Profiles
    • AstraZeneca Plc*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Fresenius Kabi
    • AbbVie Inc.
    • Baxter International Inc.
    • Braun Melsungen AG
    • Maruishi Pharmaceutical Co.,Ltd
    • Piramal Healthcare
    • Hikma Pharmaceuticals
    • Mylan N.V.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description     
      • Market Definition and Scope
      • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Developments
    • Market Trends
    • Regulatory Scenario
    • Porter Analysis
    • Pest Model
  4. India Intravenous Anesthetic Market, By Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Barbiturates
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Ketamine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Benzodiazepines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Propofol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  5. India Intravenous Anesthetic Market, By End User, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  6. Competitive Landscape
    • Company Profiles
      • AstraZeneca Plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fresenius Kabi
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Maruishi Pharmaceutical Co.,Ltd
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Piramal Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Hikma Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mylan N.V.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 13 market data tables and 11 figures on 'India Intravenous Anesthetic Market' – Global forecast to 2027

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner